Source: International Congress 2018 – Lung cancer: risk factors, supportive measures and quality improvement
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
T. Iwata (Amagasaki, Japan), A. Yamamoto (Amagasaki, Japan). Pegfilgrastim drastically lowered risk of febrile neutropenia in Japanese patients with thoracic malignancy receiving chemotherapy - a retrospective single institutional study. 2824

Member's Comments

No comment yet.

Related content which might interest you: The incidence of neutropenia in patients undergoing outpatient chemotherapy for lung cancer Source: Eur Respir J 2006; 28: Suppl. 50, 755s Year: 2006 Lung cancer patients hospitalized for febrile neutropenia: A retrospective study Source: Annual Congress 2010 - Best supportive care and palliation for lung cancer patients Year: 2010 Rescue administration of cyclophosphamide in patients with DAH - retrospective evaluation and outcome from our ICU Source: Virtual Congress 2020 – Clinical issues in granulomatous lung diseases Year: 2020 Chemotherapy induced neutropenia in lung cancer patients: a single centre study Source: Annual Congress 2009 - Treatment of lung cancer Year: 2009 Febrile episodes without leukopenia are more important for survival than febrile leukopenia in lung cancer patients receiving chemotherapy Source: Eur Respir J 2005; 26: Suppl. 49, 76s Year: 2005 The effectiveness of pegfilgrastim in preventing leucopenia in patients with lung cancer under chemotherapy Source: Eur Respir J 2005; 26: Suppl. 49, 77s Year: 2005 Study of patient nominated symptoms and changing symptamatology in patients with lung cancer receiving palliative chemotherapy Source: Eur Respir J 2005; 26: Suppl. 49, 323s Year: 2005 Treatment of chemotherapy induced febrile neutropenia in patients with lung and pleural tumours with ertapenem Source: Eur Respir J 2004; 24: Suppl. 48, 73s Year: 2004 Tofacitinib versus standard of care treatment in patients with COVID-19 pneumonia and respiratory failure: a multicenter cohort study Source: Virtual Congress 2021 – Acute COVID - 19 Year: 2021 Microbiology in lung cancer febrile neutropenia. Multicentric retrospective study Source: Annual Congress 2008 - Treatment of thoracic tumours Year: 2008 Evaluation of outpatient infections in lung cancer patients treated with chemotherapy and/or radiotherapy Source: Annual Congress 2012 - Screening, diagnosis, staging and treatment strategies for lung cancer Year: 2012 Management of chemotherapy-induced anemia in patients with lung cancer (LC): A comparative study of erythropoietic agents Source: Annual Congress 2012 - Treatment of lung cancer Year: 2012 A prospective study on lung toxicity in patients treated with paclitaxel and carboplatin Source: Eur Respir J 2001; 18: Suppl. 33, 377s Year: 2001 A retrospective analysis of methotrexate therapy as a steroid sparing agent within a UK severe asthma clinic Source: Annual Congress 2012 - Different ways to phenotype asthma Year: 2012 Are SABA-reliant asthma patients receiving adequate ICS therapy? A nationwide cohort study in Sweden (HERA) Source: International Congress 2019 – Asthma treatment: novel insights from clinical studies Year: 2019 Tocilizumab treatment for patients with Covid-19 pneumonia - a single centre observational study Source: Virtual Congress 2021 – COVID - 19 treatments Year: 2021 The efficacy and safety of induction chemoradiotherapy (ICRT) followed by surgery in stage III NSCLC patients (pts) with T3/4-adjacent organ invasion involved(AOI): A single-center retrospective observational study. Source: International Congress 2018 – Lung cancer: personalised medicine Year: 2018 Therapeutic strategy combining intravenous cyclophosphamide followed by oral azathioprine to treat worsening interstitial lung disease associated with systemic sclerosis: a retrospective multicentered open-label study Source: Annual Congress 2008 - Interstitial lung disease in systemic and vascular disorders Year: 2008 Multi-institutional prospective cohort study of prognostic factors in patients with idiopathic pulmonary fibrosis receiving long-term oxygen therapy. Source: International Congress 2019 – The world of idiopathic pulmonary fibrosis Year: 2019 Role of flexible bronchoscopy in the management of patients with febrile neutropenia and lung infiltrates in a cancer setting hospital Source: International Congress 2019 – Diagnosis of lung cancer Year: 2019